A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma

Clinical trial NCT01689519 · COMPLETED

Trial details

NCT number: NCT01689519
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2013-01-08
Primary completion: 2014-05-09
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.